tradingkey.logo
搜索

Simulations Plus Inc

SLP
添加自选
18.390USD
+0.040+0.22%
收盘 07/02, 13:00美东报价延迟15分钟
370.50M总市值
亏损市盈率 TTM

Simulations Plus Inc

18.390
+0.040+0.22%
查看详细走势图
TradingKey 图表
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

+0.22%

5天

+1.04%

1月

+10.45%

6月

+1.55%

今年开始到现在

+0.88%

1年

+3.61%

关键数据
18.450今开
18.470最高
483.05K成交量
亏损市盈率 TTM
38.16市盈率动
--股息TTM
2.40%换手率
18.350昨收
18.340最低
5.03M成交额
亏损市盈率静
2.91市净率
0.00%股息率 TTM
-36.09%ROA
32.51552周最高
1.15量比
-64.72M净利润
20.15M总股本
-3.1244每股收益TTM
1.31Beta
-38.84%ROE
11.09052周最低
0.71%振幅
66.46%毛利率
370.50M总市值
3.04回报/风险
3.36%风险率

TradingKey Simulations Plus Inc股票评分

单位: USD 更新时间: 2026-07-02

操作建议

Simulations Plus Inc当前公司基本面数据相对非常健康,增长潜力很大。当前估值合理,在医疗设备与耗材行业排名68/204位。机构持股占比非常高,近一月多位分析师给出公司评级为持有。最高目标价19.83。中期看,股价处于上升通道。近一个月,市场表现较强,技术面和基本面综合得分较高,较强的走势得到基本面和技术面的印证。目前股价在压力位和支撑位之间,可以做区间波段操作。

Simulations Plus Inc评分

相关信息

行业排名
68 / 204
全市场排名
167 / 4565
所属行业
医疗设备与耗材

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

公司舆情

过去24小时
热度

过冷
过热
极度看好

Simulations Plus Inc亮点

亮点风险
Simulations Plus, Inc. is a provider in the biopharma sector, offering advanced software and consulting services that enhance drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. It operates through two segments: software and services. The Company’s business units include cheminformatics, physiologically based pharmacokinetics, clinical pharmacology and pharmacometrics, quantitative systems pharmacology, adaptive learning & insights and medical communications. The Company operates in biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry. It delivers simulation-enabled performance and intelligence solutions alongside medical communications support for clinical and commercial drug development. Its cutting-edge technology is licensed and utilized by pharmaceutical, biotechnology, and regulatory agencies worldwide.
业绩高增长
公司营业收入稳步增长,连续3年增长32.90%
业绩增长期
公司处于发展阶段,最新年度总收入79.18M美元
业绩转亏
公司业绩转亏,最新年度亏损美元
估值低估
公司最新PE估值-5.89,处于3年历史低位
机构减仓
最新机构持股17.68M股,环比减少20.75%
查克·罗伊斯持仓
明星投资者查克·罗伊斯持仓,最新持仓市值324.76K
活跃度增加
近期活跃度增加,过去20天平均换手率0.59

分析师目标

根据 5 位分析师
持有
评级
19.833
目标均价
+8.08%
涨幅空间

Simulations Plus Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Simulations Plus Inc简介

Simulations Plus, Inc. is a provider in the biopharma sector, offering advanced software and consulting services that enhance drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. It operates through two segments: software and services. The Company’s business units include cheminformatics, physiologically based pharmacokinetics, clinical pharmacology and pharmacometrics, quantitative systems pharmacology, adaptive learning & insights and medical communications. The Company operates in biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry. It delivers simulation-enabled performance and intelligence solutions alongside medical communications support for clinical and commercial drug development. Its cutting-edge technology is licensed and utilized by pharmaceutical, biotechnology, and regulatory agencies worldwide.
公司代码SLP
公司Simulations Plus Inc
CEOO'Connor (Shawn M)
网址https://www.simulations-plus.com/

常见问题

Simulations Plus Inc(SLP)的当前股价是多少?

Simulations Plus Inc(SLP)的当前股价是 18.39。

Simulations Plus Inc的股票代码是什么?

Simulations Plus Inc的股票代码是SLP。

Simulations Plus Inc股票的52周最高点是多少?

Simulations Plus Inc股票的52周最高点是32.52。

Simulations Plus Inc股票的52周最低点是多少?

Simulations Plus Inc股票的52周最低点是11.09。

Simulations Plus Inc的市值是多少?

Simulations Plus Inc的市值是371.58M。

现在Simulations Plus Inc(SLP)的股票是买入、持有还是卖出?

根据分析师评级,Simulations Plus Inc(SLP)的总体评级为signal_hold,目标价格为19.83。

Simulations Plus Inc(SLP)股票的每股收益(EPS TTM)是多少

Simulations Plus Inc(SLP)股票的每股收益(EPS TTM)是-3.22。